Desmoid Fibromatosis
9 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery (NCT04195399) | Children's Oncology Group | 2020-10-07 |
| Observing People With Desmoid-Type Fibromatosis (NCT04281381) | Memorial Sloan Kettering Cancer Center | 2020-02-19 |
| Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis (NCT03966742) | Rabin Medical Center | 2018-10-11 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
| Project: Every Child for Younger Patients With Cancer (NCT02402244) | Children's Oncology Group | 2015-11-03 |
| Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis (NCT02066181) | National Cancer Institute (NCI) | 2014-03-21 |
Track Desmoid Fibromatosis automatically
Every clearance here is in the API, with alerts when new ones post.